Environmental Mutagenesis and Genomics Society

51st Annual Meeting in Palm Springs, CA

September 12 - 16, 2020

Established scientists, new investigators, postdoctoral fellows and students –

I extend a warm welcome and cordially invite you to attend the 51st Annual Meeting of the Environmental Mutagenesis and Genomics Society (EMGS). On September 12-16, 2020, we will gather in Palm Springs, CA to study groundbreaking research, network with other peers and discuss topics related to mutagenesis, DNA repair, genomics, genetic toxicology, epigenetics, heritable diseases, and other fields. 

This year, we are pleased to welcome a stellar cast of keynote speakers, including: 

• Dr. Mary Claire King of the University of Washington, who is renowned for her work on genetic determinants of human disease
• Dr. Kari Stephansson, pioneer in analysis of human DNA sequence variation 
• Dr. Serena Nik-Zainal, a CRUK Advanced Clinician Scientist and Honorary Consultant in Clinical Genetics from Cambridge University
• Dr. Joan Steitz, my former college professor, who has made seminal discoveries about small non-coding RNAs 

Fifteen symposia on topics of societal interest are on the docket, as well as social activities involving a pool, a local brewery and dancing. And you definitely won't want to miss the early morning meetings of our special interest groups! 

Come join us for great science, targeted support for your career stage, intimate views of Joshua trees and lots of good fellowship!

William Kaufmann, Ph.D., EMGS President

About the EMGS

The EMGS Vision

To promote critical scientific knowledge and research into the causes and consequences of damage to the genome and epigenome in order to inform and support national and international efforts to ensure a healthy, sustainable environment for future generations.

Mission of the EMGS

The EMGS mission is (1) to foster scientific research and education on the causes and mechanistic bases of DNA damage and repair, mutagenesis, heritable effects, epigenetic alterations in genome function, and their relevance to disease, and (2) to promote the application and communication of this knowledge to genetic toxicology testing, risk assessment, and regulatory policy-making to protect human health and the environment.